Dechra® Pharmaceuticals PLC
(the "Company" or the "Group")
Results of Annual General Meeting ("AGM")
Dechra Pharmaceuticals PLC announces that all resolutions proposed at its AGM held on 5th November 2010 were duly passed on a show of hands.
In accordance with Listing Rule 9.6.2 and 9.6.3, copies of the resolutions (other than resolutions concerning ordinary business) passed by the Company at its AGM held on 5th November 2010 have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.hemscott.com/nsm.do.
Details of the proxy voting instructions lodged prior to the AGM are set out below:
Resolution (No. as noted on proxy form) |
For |
Against |
Discretionary |
Withheld |
Resolution 1: To receive and consider report and accounts |
47,919,958 |
0 |
102,111 |
0 |
Resolution 2: To receive and approve Directors Remuneration Report |
47,523,944 |
393,108 |
101,011 |
4,006 |
Resolution 3: To declare a final dividend |
47,921,058 |
0 |
101,011 |
0 |
Resolution 4: To elect Bryan Morton |
47,687,639 |
230,449 |
101,661 |
2,320 |
Resolution 5: To re-elect Edwin Torr |
47,691,199 |
228,109 |
101,661 |
1,100 |
Resolution 6: To re-elect Michael Redmond |
47,302,278 |
230,775 |
101,661 |
387,355 |
Resolution 7: To re-appoint KPMG Audit plc as Auditors |
47,829,290 |
90,548 |
101,011 |
1,220 |
Resolution 8: To authorised the Directors to fix the Auditors remuneration |
47,830,630 |
89,208 |
101,011 |
1,220 |
Resolution 9: To grant authority to allot equity securities
|
46,444,172 |
57,769 |
97,961 |
1,422,167 |
Resolution 10: To renew authority for pre-emptive allotment of equity securities
|
47,908,271 |
12,223 |
97,961 |
3,614 |
Resolution 11: To grant authority to the Company to purchase
|
47,912,955 |
11,153 |
97,961 |
0 |
Resolution 12: To call general meetings (other than an AGM) on not less than 14 clear days notice
|
47,164,556 |
749,386 |
97,961 |
0 |
Resolution 13: To approve the amendments to the Approved Share Option scheme |
46,483,131 |
7,353 |
101,011 |
1,430,574 |
Resolution 14: To approve the amendments to the Unapproved Share Option scheme |
47,885,211 |
9,793 |
101,011 |
26,054 |
Resolution 15: To approve the amendments to the Save as You Earn Option scheme |
47,878,999 |
17,671 |
101,011 |
24,388 |
Enquiries:
Zoe Goulding, Company Secretary
Dechra Pharmaceuticals PLC
Tel: +44(0) 1782 771100
Dechra and the Dechra 'D' logo are registered Trade Mark of Dechra Pharmaceuticals PLC